Braveheart Bio is a Bay Area–based biopharmaceutical company pioneering best-in-class therapies for cardiovascular disease. Our lead program is a next-generation myosin inhibitor, licensed from Hengrui Pharma, being developed to transform the treatment of hypertrophic cardiomyopathy (HCM)—the most common inherited cardiac disease. Currently in Phase 3 clinical development in China for the more common obstructive form of HCM, our candidate has demonstrated a compelling clinical profile that may position it as a best-in-class therapy with meaningful differentiation. With a proven leadership team, a strong financial foundation, and a high-value late-stage asset, Braveheart Bio represents an outstanding opportunity for ambitious, mission-driven professionals to make a tangible impact in a high-profile and rapidly evolving therapeutic area. The Director/Sr. Director, Data Management is responsible for ensuring the integrity, quality, and timely delivery of all clinical trial data across our cardiovascular portfolio. This role will be responsible for developing and executing data management strategy across late-stage clinical programs, with a strong emphasis on vendor oversight, data quality, inspection readiness, and cross-functional collaboration. The ideal candidate brings deep hands-on data management expertise, thrives in a lean and fast-moving biotech environment, and is comfortable operating both strategically and tactically. This role is accountable for the development and implementation of a robust data management strategy, including the oversight of internal teams and external vendors (CROs). The ideal candidate requires a detailed knowledge of clinical data management processes, platforms, software, clinical trial databases, and the pharmaceutical drug development process.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director